[1]罗蓉,杨勇毅.新型冠状病毒肺炎疫情期间临床用血状况分析及供血策略[J].西部中医药,2022,35(08):86-88.[doi:10.12174/j.issn.2096-9600.2022.08.20]
 LUO Rong,YANG Yongyi.Analysis of Clinical Blood Usage and Blood Supply Strategy during the COVID-19 Pandemic[J].Western Journal of Traditional Chinese Medicine,2022,35(08):86-88.[doi:10.12174/j.issn.2096-9600.2022.08.20]
点击复制

新型冠状病毒肺炎疫情期间临床用血状况分析及供血策略
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年08期
页码:
86-88
栏目:
调查分析
出版日期:
2022-08-15

文章信息/Info

Title:
Analysis of Clinical Blood Usage and Blood Supply Strategy during the COVID-19 Pandemic
作者:
罗蓉1 杨勇毅2
1.兰州现代职业学院,甘肃 兰州 730000
2.甘肃省红十字血液中心
Author(s):
LUO Rong1 YANG Yongyi2
1.Lanzhou Modern Vocational College, Lanzhou 730000, China
2.Gansu Provincial Red Cross Blood Center
关键词:
新型冠状病毒肺炎临床用血供血策略
Keywords:
COVID-19clinical blood useblood supply strategy
分类号:
R826.2+6
DOI:
10.12174/j.issn.2096-9600.2022.08.20
摘要:
目的探讨新型冠状病毒肺炎(Corna Virus disease 2019,COVID-19)(简称新冠肺炎)疫情期间甘肃某地区临床用血状况,制定供血策略。 方法回顾性分析、比较甘肃某地区2020年1月25日至5月11日发生第一轮新冠疫情时及2018年、2019年同时期100多家用血单位的用血数据,该地区2021年10月18日至11月27日发生第二轮新冠疫情时及2020年同时期的用血数据。 结果总用血量2020年1月25日至5月11日与2018年同期相比略有减少,但差异无统计学意义(P>0.05),上述两时期与2019年同期比较,差异均有统计学意义(P<0.05)。总用血量2021年10月18日至11月27日与2020年同期相比明显减少,差异有统计学意义(P<0.05)。新冠肺炎患者用血量占总用血量的份额较小。6家三级医院2018—2020年三个时期用血量比较,差异无统计学意义(P<0.05)。 结论新冠疫情发生期间总用血量有所减少,但三级医院变化不大,非新冠肺炎患者的临床用血占主要地位,必须要加强血液库存管理,制定供血策略,以保障临床用血。
Abstract:
ObjectiveTo explore clinical blood usage in a place of Gansu during COVID-19 pandemic and establish blood supply strategy. MethodsThe data of blood use in more than 100 units in the same period of 2018 and 2019, and in the first round of COVID-19 pandemic between January, 25 and May 11, 2020 in a place of Gansu were retrospectively analyzed and compared, as well as the data of blood use in the same period of 2020 and in the second round of COVID-19 pandemic between October 18, 2021 and November 27, 2021 in the same place. ResultsThe total blood consumption between January 25 and May 11, 2020 was slightly lowered compared with the same period in 2018, while the difference had no statistical meaning (P>0.05), the difference had statis-tical meaning when the two periods above were compared with the same period of 2019 (P<0.05). The total blood consumption from October 18, 2021 to November 27, 2021 was remarkably reduced compared with the same period of 2020 (P<0.05). The share of blood use of COVID-19 in total blood use was smaller. The difference had no statistical meaning in blood consumption between three periods of 2018 and 2020 in six tertiary hospitals (P<0.05). ConclusionTotal blood consumption have reduced during COVID-19 pandemic, however, the change in tertiary hospitals is insignificant, clinical blood use of non-COVID-19 patients hold the main position, we should enhance blood inventory management, and formulate blood supply strategy to guaranteem clinical blood use.

相似文献/References:

[1]陈进凡,杨勇毅,张晓萍,等.甘肃省三级以上医疗机构临床合理用血现状调查[J].西部中医药,2018,31(02):76.
 CHEN Jinfan,YANG Yongyi,ZHANG Xiaoping,et al.Investigation into the Current State of Rational Clinical Blood Use in Grade-A Tertiary Hospital of Gansu[J].Western Journal of Traditional Chinese Medicine,2018,31(08):76.
[2]李赟,王彩弟,王建云,等.简约远程中医诊疗在新型冠状病毒肺炎隔离病区中的应用[J].西部中医药,2020,33(S1):1.
 LI Yun,WANG Caidi,WANG Jianyun,et al.The Application of Simple Remote TCM Diagnosis and Treatment to COVID-19 Quarantined Inpatient Area[J].Western Journal of Traditional Chinese Medicine,2020,33(08):1.
[3]宋忠阳,雍文兴,张利英,等.新型冠状病毒肺炎的中医临床特征与辨证论治——甘肃经验*[J].西部中医药,2020,33(S1):3.
 SONG Zhongyang,YONG Wenxing,ZHANG Liying,et al.The Experience of TCM Clinical Characteristics, Syndrome Differentiation and Treatment for COVID-19 in Gansu Province[J].Western Journal of Traditional Chinese Medicine,2020,33(08):3.
[4]杜洪霖,马战平△.西北地区新型冠状病毒肺炎的中医特点及防治*[J].西部中医药,2020,33(S1):5.
 DU Honglin,MA Zhanping.TCM Characteristics, the Prevention and Treatment of COVID-19 in Northwest China[J].Western Journal of Traditional Chinese Medicine,2020,33(08):5.
[5]潘文,李盛华,王晓萍,等.中医对新型冠状病毒肺炎的认识与防治探讨[J].西部中医药,2020,33(S1):7.
 PAN Wen,LI Shenghua,WANG Xiaoping,et al.On TCM Understanding, the Prevention and Treatment of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(08):7.
[6]杨海侠,张银萍△,杨长虹,等.新型冠状病毒肺炎疑似患者留观隔离期的护理体会[J].西部中医药,2020,33(S1):13.
[7]丁潇,邹忆怀△,辛大永,等.北京顺义地区新型冠状病毒肺炎的中医临床证候与CT表现[J].西部中医药,2020,33(S1):16.
 DING Xiao,ZOU Yihuai,XIN Dayong,et al.TCM Clinical Syndromes and CT Manifestations of COVID-19 in Shunyi District of Beijing[J].Western Journal of Traditional Chinese Medicine,2020,33(08):16.
[8]桑天庆,周红光△.中医药在新型冠状病毒肺炎疫情中的应用[J].西部中医药,2020,33(S1):18.
 SANG Tianqing,ZHOU Hongguang.TCM Applied to Epidemic Situation of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(08):18.
[9]闫向勇,李 俊,燕忠生△.武汉地区新型冠状病毒肺炎中医证候及病机特点[J].西部中医药,2020,33(S1):20.
 YAN Xiangyong,LI Jun,YAN Zhongsheng.On the Characteristics of TCM Patterns and the Pathogenesis of COVID-19 in Wuhan Region[J].Western Journal of Traditional Chinese Medicine,2020,33(08):20.
[10]曾建峰,李乐愚,缪灿铭,等.岭南道地药材在中山地区新型冠状病毒肺炎防治中的应用*[J].西部中医药,2020,33(S1):24.[doi:10.1056/NEJMoa-2001017]
 and Treatment of COVID-9 in Zhongshan Region.The Application of Lingnan Genuine Drugs to the Prevention[J].Western Journal of Traditional Chinese Medicine,2020,33(08):24.[doi:10.1056/NEJMoa-2001017]

备注/Memo

备注/Memo:
罗蓉(1974—),女,讲师。研究方向:生物化学。甘肃省卫生行业科研管理项目(GWGL2011-17)。
更新日期/Last Update: 2022-08-15